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ABSTRACT
Background/aims Descemet membrane endothelial 
keratoplasty (DMEK) preparation is technically 
demanding and is a limiting factor for uptake of this kind 
of surgery. Supply methods that simplify the procedure 
for surgeons are key to increasing uptake. This study 
compares two different shipping protocols for DMEK.
Methods An 8.5 mm DMEK graft was punched, marked 
and loaded for transportation in two different conditions: 
(A) endothelium trifolded inwards in organ culture 
conditions (n=7) and (B) endothelium rolled outwards 
in hypothermic conditions (n=7). Tissues were shipped 
from Italy to the UK, then analysed for orientation, 
endothelial cell density, denuded areas, cell mortality, 
triple viability staining (Hoechst/ethidium homodimer/
calcein AM (HEC)), immunolocalisation of ZO-1 and 
Na/K-ATPase proteins, visualisation of actin filaments 
using phalloidin and histological analysis using H&E on 
paraffin-embedded sections.
Results All tissues clearly showed the mark used for 
graft orientation. After shipping in condition A, there was 
an increase in cell mortality of 8.1% and in denuded 
areas of 22.4%, whereas for condition B there was an 
increase in cell mortality of 14.2% and in denuded areas 
of 34.3% after shipping. HEC staining revealed areas of 
viable cells and apoptotic cells, with large denuded areas 
found in the periphery for condition B and within folds 
for condition A.
Conclusions Prestripped preloaded DMEK grafts 
retained sufficient viable cells for transplantation, with 
condition A (endothelium-in) offering the advantage of 
greater flexibility of use due to a longer shelf-life. HEC 
analysis provides further detailed information as to the 
status of DMEK grafts and should be used in future 
similar studies.
InTRoduCTIon
Corneal transplantation is one of the most 
frequently performed types of transplant proce-
dure. Despite a large potential donor pool, there 
exists a global shortage of eye donors.1 A recent 
epidemiological study estimated that only one 
cornea is available for every 70 needed, with some 
countries having no access to suitable tissue.2 
In order to overcome this shortage and improve 
outcomes, there has been a rapid increase in the 
number of lamellar surgeries, and the advantages 
of lamellar keratoplasty over full-thickness kera-
toplasty are now well established.3 There is also 
increasing evidence that Descemet membrane 
endothelial keratoplasty (DMEK) shows supe-
rior outcomes compared with Descemet stripping 
automated endothelial keratoplasty in terms of 
visual outcomes and rehabilitation rates.4 Uptake 
of DMEK, however, is relatively low, possibly 
because of the skill required in graft preparation. 
Precut, preloaded tissue, therefore, presents several 
advantages. For the hospital and surgeon there is 
reduced complexity, time and associated costs; 
for the patient, there is improved validation and 
quality control that are difficult to undertake in the 
surgical theatre; and for the eye bank, it enables the 
use of one cornea for more than one recipient. It is 
essential therefore to optimise the preparation and 
transport of prestripped, preloaded tissue.
Currently, there are only two preloaded DMEK 
shipping protocols, originating from the USA5 
and from Italy.6 Tran et al have described loading 
the DMEK graft into a delivery device, such as a 
modified Jones tube, with the endothelium facing 
outwards. Scrolling of Descemet’s membrane with 
the endothelium out is the spontaneous form that 
the tissue takes within a liquid. This, however, 
makes handling of the tissue difficult and exposes 
the endothelial cells to potential damage against the 
wall of the delivery tube during both loading and 
insertion. In contrast, the Veneto Eye Bank Founda-
tion (FBOV) and colleagues describe methods with 
endothelium trifolded inwards, which may facilitate 
insertion of the tissue both within the introducer 
and also into the eye with less potential damage to 
the endothelium.6–8
The aim of this study was to compare these 
two contrasting protocols to assess their effect 
on endothelial cell survival in preloaded DMEK 
grafts in order to determine the optimal shipping 
condition. Determining the most appropriate 
protocol will facilitate further uptake of DMEK 
surgery and potentially deliver more consistent 
and improved surgical outcomes. This would 
enable an eye bank to ensure high-quality tissues 
are provided to corneal surgeons in numerous 
remote locations across the world where access 
may be limited.9 10
MeThodS
ethical statement
Fourteen human cadaveric donor corneoscleral 
discs were obtained from FBOV, Venice, Italy, 
following consent from the donor’s next of kin.
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Shipping conditions
Condition A was endothelium-flapped inwards and tissue 
preserved in organ culture medium supplemented with 6% 
dextran T500 (transport medium) and shipped at room tempera-
ture (RT) (figure 1A). For condition B, the endothelium was 
scrolled outwards in a modified Jones tube preserved in hypo-
thermic medium (Optisol-GS, Bausch & Lomb, Bridgewater, NJ, 
USA) at 4°C during transportation (figure 1B).
Preparation of donor tissues in the eye bank for shipment
Stripping method
The corneoscleral discs (n=14) were centred on a vacuum 
punch base with a vacuum created using a syringe. A 9.5 mm 
trephine (Moria, Antony, France) was used to make a superficial 
cut using a gentle tapping method. The endothelium was stained 
with trypan blue (0.4%) for approximately 20 s to determine 
the area of the cut. Excess peripheral membrane was removed 
using 120 mm acute forceps (e.janach, Como, Italy). The endo-
thelium was kept moist during the entire procedure using trans-
port media. The membrane was slightly lifted and scored using 
a cleavage hook around the entire circumference of the cut to 
ensure minimal tearing of the DMEK tissue while stripping. The 
DMEK tissue was stripped using a four-quadrant method leaving 
a hinge behind. Using a skin biopsy punch, a stromal hole was 
created to mark the endothelium (Descemet’s membrane side) 
with ‘F’ using a skin marker to aid orientation. Maintaining the 
correct orientation of the donor graft during DMEK surgery 
is crucial. If the graft orientation is incorrect on attachment to 
the corneal stromal surface, primary graft failure may occur. 
The DMEK tissue was replaced back on the posterior stroma. 
The tissue was inverted and the stromal piece (punch site) was 
removed to mark ‘F’ on the Descemet’s membrane, the stromal 
piece was replaced back, and the corneal tissue was reinverted 
and fixed again on the vacuum base for loading.
Loading method of endothelium-in preloaded DMEK preserved in 
transport medium (condition A)
As described previously,6 the prestripped membrane (9.5 mm) 
was retrephined with an 8.5 mm punch (Moria) and the excess 
periphery was removed, maintaining the endothelial side face up 
(n=7). The membrane was folded manually from two opposite 
ends using acute forceps, touching the Descemet’s side to avoid 
endothelial damage. Only a small drop of liquid was added to 
the membrane to maintain tissue moisture throughout without 
allowing opening of the membrane, as this may change the 
orientation. The membrane was carefully moved from the tissue 
base to a 2.2 intraocular lens (IOL) cartridge (Viscoject, Wolf-
halden, Switzerland) using a contact lens as a carrier to maintain 
the architecture and orientation of the membrane, as previously 
described.8 The membrane was pulled inside the funnel using 
Grieshaber Revolution DSP 25 G end-grasping forceps (Alcon, 
Fort Worth, Texas, USA). A small amount of transport medium 
(<0.5 mL) was used to fill the funnel of the IOL cartridge for 
preservation of the DMEK membrane. The IOL cartridge was 
sealed with a rubber plug at both the funnel and the rear exit. The 
entire unit was sealed with in-house modified rubber clamps and 
preserved in a sterile phial with transport media. The preloaded 
tissues were shipped at RT to the University of Liverpool, UK, 
for further analysis (figure 1A).
Loading method of endothelium-out preloaded DMEK preserved in 
Optisol-GS (condition B)
As described earlier by Parekh et al,6 following stripping of 
the Descemet's membrane (DM), the grafts were freed from 
the corneal hinge and immediately placed onto a Petri dish 
containing phosphate buffered saline (PBS; n=7). The graft, as 
expected, rolled with the endothelium outwards. Using a modi-
fied Jones tube and a syringe filled with Optisol-GS, the graft 
was aspirated inside the modified Jones tube. The entire unit was 
placed in an Eppendorf tube (2 mL) filled with Optisol-GS and 
shipped in hypothermic conditions (on wet ice) to the University 
of Liverpool, UK, for further analysis (figure 1B).
Tissue analysis with light microscopy
The tissues were analysed before preloading at FBOV and 
then after the shipment to Liverpool, UK (n=14). The endo-
thelial layer was examined at FBOV using an inverted micro-
scope (Primovert; Zeiss, Jena, Germany) for endothelial cell 
number, denuded areas, cell mortality and tissue integrity, and 
presence of ‘F’ orientation mark. The cells were counted using a 
10×10 eyepiece reticule and the images were captured at 100× 
magnification. In Liverpool, the tissues were released from their 
shipping vessels using end-grasping forceps and analysed. The 
membranes were stained with trypan blue for 20 s and washed 
with PBS before further analysis.
histological staining
After shipping, two tissue samples from each condition were 
fixed in 4% paraformaldehyde (PFA), placed on an automated 
processor overnight and embedded in paraffin prior to sectioning 
and histological staining. H&E staining was performed on 
sections to determine any macro changes in DM thickness and 
the presence of a continuous endothelial layer. Tissue thickness 
was measured using Fiji image analysis software.
Figure 1 Schematic to depict the two different shipping conditions 
for Descemet membrane endothelial keratoplasty (DMEK) grafts. (A) 
Condition A with endothelium-in stored in organ culture medium, and 
(B) condition B with endothelium-out and stored in Optisol. The arrows 
on the bottom of the two images indicate the position of the trypan 
blue-stained scroll within the vessel ready for shipping. The intraocular 
lens (IOL) cartridge is sealed with stoppers and the Jones tube loaded 
into an Eppendorf tube.
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Tissue fixation and preparation for immunostaining
Samples from each condition were unfolded and placed on a 
glass slide with endothelium face up. The tissues were fixed in 
4% PFA at RT for 30 min. Three tissues were halved and anal-
ysed for presence of ZO-1 (n=3), Na+/K+ATPase (n=3) and 
phalloidin (n=1). The cells were permeabilised with 0.1% Triton 
X-100 in PBS for 30 min. After blocking with 10% normal goat 
serum, the tissues were incubated overnight at 4°C with primary 
antibodies (table 1). The samples were incubated with goat anti-
mouse/rabbit Alexa Fluor 488 secondary antibody in PBS for 
2 hours at RT in the dark. For phalloidin staining, tissue was 
incubated for 2 hours at RT in the dark. Cells were counter-
stained with 4’,6-diamidino-2-phenylindole, dilactate (DAPI) for 
10 min at RT. After each step, the cells were washed three times 
with PBS and mounted with coverslips and hard set mounting 
medium. Cells were examined with an LSM 800 confocal micro-
scope (Zeiss).
endothelial cell triple staining viability assay
Whole DMEK tissue was triple-stained to determine the 
viability and coverage of endothelial cells after transport using 
a Hoechst/ethidium homodimer/calcein AM (HEC) combina-
tion as previously described by Pipparelli et al.11 Cells that are 
not actively converting calcein but whose membranes are not 
yet permeable to EthD-1 will stain with Hoechst alone, which 
we have termed here as intermediate cells. The DMEK tissues 
were washed with PBS prior to the assay to remove or dilute 
serum esterase activity generally present in serum-supplemented 
growth media. Hoechst 33 342 (H; 3 µg/mL, Thermo Fisher 
Scientific, Rochester, New York, USA), ethidium homodimer 
EthD-1 (E; 0.8 µM) and calcein AM (C; 0.4 µM) (LIVE/DEAD 
Viability/Cytotoxicity Kit, Thermo Fisher Scientific) were added 
to PBS. Approximately 200 µL of the final solution was added 
to the DMEK tissue on a glass slide and incubated at RT in the 
dark for 45 min. Relaxing radial cuts were made at three points 
to obtain a flat mount and tissue protected with a coverslip 
without mounting medium. HEC staining was viewed with an 
LSM 800 confocal microscope. A tile scan was performed using 
a 5× objective and reconstructed using ZEN processing soft-
ware to produce an image of staining across the whole surface 
of the graft. Trainable Weka segmentation on Fiji was used to 
analyse the percentage area covered by viable cells, intermediate 
cells and denuded areas as previously described by Jardine  et 
al.12 Briefly, the images were converted into 16-bit, black and 
white, and the pixel intensity adjusted for contrast. The train-
able segmentation plugin was activated and classes assigned to 
live, intermediate and denuded areas. The software was then 
trained to detect these areas and then train classifier selected; 
retraining was performed if necessary. A final segmentation was 
produced, and using the histogram feature on Fiji a pixel count 
was acquired to derive a percentage for each category. General 
instructions for use of this plugin can be found at http:// Fiji. sc/ 
Trainable_ Segmentation_ Plugin.
Statistical analysis
Data are expressed as mean±SD and paired data were anal-
ysed using paired Wilcoxon test for non-parametric data. P 
value <0.05 was considered significant.
ReSuLTS
donor characteristics
Average donor age was 72.5 (±6.8) years with 11 men and three 
women. The average postmortem interval between death and 
retrieval was 9.8 (±3.9) hours.
Tissue preparation
Time to prepare (second punch, folding and loading) tissue in 
condition A was approximately 20 min compared with condi-
tion B which took only 5 min, which is similar to previously 
published results.7 Peeling success was 100% (n=14). Time of 
shipment between Italy and UK was approximately 20 hours. 
All the tissues were analysed between 48 and 72 hours after 
preloading.
Initial tissue analysis after shipping
All but one of the tissues were clearly visible in their delivery 
device. One preloaded graft required restaining with trypan 
blue to aid visualisation. The ‘F’ mark to indicate orientation 
was prominent on all the samples; however, there was evidence 
of cell loss surrounding marks (figure 2A,D). For condition A, 
the endothelial cell density was 1928.57 (±111.27) cells/mm2 
before shipping and on second analysis there was an increase 
in cell mortality, as indicated by trypan blue staining, from 
1.93% (±3.59) to 10.0% (±5.77) and denuded areas from 0% 
to 22.43% (±13.89). Meanwhile for condition B, the endothe-
lial cell density was 1785.71 (±146.39) cells/mm2, with cell 
mortality increased from 6.57% (±3.91) to 20.7% (±30.72) 
and denuded areas from 0% to 34.28% (±15.11) after shipping. 
There was no statistically significant difference in cell mortality 
and denuded areas between the two conditions for these param-
eters. Figure 2 shows the far periphery of the endothelium 
(figure 2B,E) and the central endothelium after shipping of the 
preloaded DMEK grafts (figure 2C,F).
histological examination of dMeK tissue
H&E staining revealed a monolayer of cells, and tissue thickness 
was on average 3.61 µm (±0.64) for condition A and 4.59 µm 
(±0.89) for condition B (figure 3). This indicated no macro-
scopic changes in DM thickness and distribution of endothelial 
cells after shipping.
expression of functional proteins in endothelial cells on 
dMeK tissue
The expression of ZO-1, Na+/K+ATPase and f-actin was anal-
ysed in whole-mount DMEK tissue (figure 4). Phalloidin staining 
revealed heterogeneous f-actin distribution throughout the endo-
thelial layer in condition A (figure 4A), with some areas showing 
intense cortical f-actin staining and condensed foci at the Y-junc-
tions with neighbouring cells. The distribution of f-actin in 
condition B (figure 4D) cells was generally homogeneous with 
Table 1 Details of antibody and stain concentrations
Antibody/stain Supplier Concentration
Zonula Occludens-1 (ZO-1) 
(mouse)
Thermo Fisher Scientific 
(40–2200)
2.5 µg/mL
Na+K+ATPase (rabbit) Santa Cruz (sc-71638) 5 µg/mL
Goat antirabbit Alexa Fluor 488 
secondary
Thermo Fisher Scientific 
(A11008)
4 µg/mL
Goat antimouse Alexa Fluor 488 
secondary
Thermo Fisher Scientific 
(A11001)
4 µg/mL
Alexa Fluor 488 phalloidin Thermo Fisher Scientific 
(A12379)
2 units/mL
DAPI dilactate Thermo Fisher Scientific 
(D3571)
300 nM
DAPI, 4’,6-diamidino-2-phenylindole.
 o
n
 28 August 2018 by guest. Protected by copyright.
http://bjo.bmj.com/
Br J O
phthalm
ol: first published as 10.1136/bjophthalmol-2017-310906 on 13 November 2017. Downloaded from 
552 Romano V, et al. Br J Ophthalmol 2018;102:549–555. doi:10.1136/bjophthalmol-2017-310906
Laboratory science
prominent staining of cortical f-actin bundles running parallel to 
cell borders. ZO-1 expression (figure 4B,E) was similar between 
shipping conditions with a discontinuous expression observed 
at the cell borders. Na+/K+ATPase expression was also compa-
rable between conditions, localised to the cell membranes 
(figure 4C,F).
heC triple viability staining of dMeK tissue
HEC was used to identify distinct areas of viable, non-viable, 
intermediate cell-covered areas as well as denuded areas across 
the whole tissue in both conditions (figure 5A–C). Using the 
Weka trainable segmentation plugin on Fiji, the percentage areas 
covered by viable, intermediate cells and denuded areas could 
be quantified (figure 5D–I and table 2). There appeared to be a 
higher number of viable cells present on the graft after shipping 
in condition A compared with B, and large denuded areas were 
visible in the condition B graft.
dISCuSSIon
DMEK requires great skills in both the surgical delivery of the 
graft to the posterior cornea and also the preparation of tissue. 
There is a necessity to develop methods to increase the uptake of 
the DMEK procedure by surgeons worldwide. Preloaded grafts 
can reduce the amount of tissue wastage and reduce surgery time 
as the process is performed by highly trained and experienced 
eye bank staff. In addition to conventional endothelium-out 
Figure 2 Representative images of the F mark (A,D), denuded areas in the periphery of grafts (stars; B,E) and central endothelial cells (C,F) after 
shipping of preloaded Descemet membrane endothelial keratoplasty tissues in condition A (A–C) and condition B (D–F). Scale bars: 250 µm.
Figure 3 H&E-stained sections of Descemet membrane endothelial keratoplasty (DMEK) tissue after shipping in condition A (A,C) and condition B 
(B,D). Note that the thickness of the DMEK grafts are comparable, and in both conditions there is a visible monolayer of endothelial cell nuclei stained 
with haematoxylin. Scale bars: A and B: 100 µm; C and D: 10 µm.
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preloaded DMEK grafts, preloaded DMEK grafts have been 
produced with the endothelium folded in (the opposite way to its 
natural scrolling tendency), in an attempt to decrease endothelial 
cell loss due to contact with delivery device and to increase the 
ease of opening of tissue inside the anterior chamber.13
This study shows that both preloaded DMEK protocols 
retained sufficient viable cells for transplantation. Denuded 
areas, cell mortality and live/dead/apoptotic analyses suggest a 
trend towards increased viability with preloaded DMEK endo-
thelium-in (condition A), although this result is limited by the 
small sample size. It is worth noting that the size of the shipping 
vessel may play a role in the degree of cell loss, in particular in 
the endothelial-out scrolls as they will contact the vessel walls 
during the shipping process. This is a preloaded method with 
the graft shipped ready for injection into the anterior chamber, 
however, so there is a limit to the size/shape of vessel that can 
be used as the graft needs to be easily injected from the shipping 
vessel. It was interesting to note the high levels of intermediate 
cells in both conditions. These cells were not actively converting 
the calcein AM to calcein, but their membranes were not yet 
permeable to ethidium. This population may be missed using 
conventional live/dead viability staining, and so this test should 
be included in the future to give a clearer picture of cell health 
in similar studies or in studies of endothelial cell health related 
to postmortem time from death to enucleation, for example. 
The conventional method of imaging and recording endothelial 
density does not provide as much information as triple staining 
of the whole graft surface and delineation of denuded areas. 
Immunocytochemical staining of grafts using ZO-1 and Na+/
K+ATPase antibodies to ensure tight junctions are intact and 
surface pumps are functional suggested that the majority of cells 
still remaining on the surface of the graft are functional.
The F mark to enable orientation of the graft was prominent 
in all the tissues; however, it was noted that there was occasion-
ally an area of surrounding damage at the sites where the mark 
was present with either high amounts of mortality or denuded 
areas. It is worth noting that the F mark is usually the point 
where the microforceps contact the graft while inserting into the 
IOL cartridge or during implantation. Therefore, denuded areas 
at that point could be expected and may not be solely due to the 
method of producing the F mark. The F mark in condition B 
grafts resulted in some cell mortality but not in denuded areas as 
there was no direct contact with the forceps. We have previously 
noted that the F mark induces around 0.5%–1% cell mortality 
of the whole tissue.8 This level of cell loss may be acceptable as 
marking the graft helps to reduce intraocular manipulation of 
the graft, reduce surgery time, and therefore reduce the rate of 
primary graft failure. Others have tried alternative methods such 
as three semicircular marks at the periphery of the graft made 
using a 1 mm trephine,14 or making a single peripheral trian-
gular mark with an area of 0.44 mm2.15 The physical removal of 
tissue obviously leads to the loss of a proportion of tissue and 
endothelial cells and could lead to decreased graft attachment 
at the periphery, but is perhaps a more durable solution rather 
than marking with a letter, although in our study all F marks 
were clearly visible after shipping. At this stage, the choice of 
Figure 4 Representative images showing expression of f-actin (A,D; phalloidin-stained, green), ZO-1 (B,E; green) and Na+/K+ATPase (C,F; green) in 
endothelial cells counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (blue) after shipping in condition A (A–C) or condition B (D–F). Insets in A 
and D show higher magnification of phalloidin-stained areas. Scale bars: A and D: 100 µm; B, C, E and F: 50 µm.
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marking method may be purely based on personal preference of 
the surgeon.
The aim of this study was to compare two different preloaded 
DMEK protocols in their entirety. Therefore, in addition to 
the comparison of shipping/graft delivery device, our study 
compared two different types of storage medium used in 
the different protocols. European eye banks store corneas in 
organ culture medium at 31°C after retrieval from cadavers 
and before transplantation. The tissues are then transferred 
into dextran-based medium for shipping to reduce the oedema 
and related corneal thickness.16 In contrast, in the USA, the 
tissues are preserved throughout the storage period in hypo-
thermic medium containing dextran and maintained at 4°C.17 
The advantage of the organ culture-stored corneas is that they 
have a longer shelf-life, approximately 30 days compared with 
14 days for hypothermic stored tissue, which gives increased 
flexibility for their usage. Our previous study has shown that 
Figure 5 Confocal images of HEC staining of grafts after shipping in condition A (A) and B (B). Note the relaxing incisions to enable flat mounting 
of grafts (A,B; white arrows). Calcein viable cells (green and X) and Hoechst intermediate cells (blue and star) can be seen in whole mount images. 
Denuded areas (arrow) and ethidium homodimer non-viable cells (red and chevron) can be seen at higher magnification (C). Weka segmentation 
processing of a graft shipped in condition A (D–F) and condition B (G–I). Confocal images of HEC-stained DMEK grafts were processed using Fiji into 
16-bit images (D,G), then training was performed using Weka segmentation to define the areas of live (yellow), intermediate (red) and denuded areas 
(green; E,H). The final segmentation image result was then reproduced in three colours that were quantified with Fiji histogram tool (F,I). Scale bars: 
A and B: 1 mm; C: 200 µm. DMEK, Descemet membrane endothelial keratoplasty; HEC, Hoechst/ethidium homodimer/calcein AM.
Table 2 Percentage area of Descemet membrane endothelial 
keratoplasty tissue covered by viable and intermediate cells and 
denuded areas
Condition Viable (%) Intermediate (%)
denuded areas 
(%)
A 70.1 24.4 5.5
B 37.8 30.9 31.3
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excising a DMEK graft that has been stored in dextran-based 
medium is easier (100% success) compared with excision 
from organ culture media without dextran (76% success).18 
Standardised preparation methods may further reduce graft 
wastage. In our earlier studies we have shown that preloading 
a DMEK graft in an IOL cartridge does not lead to significant 
cell loss (<10%) when preserved in dextran-based medium at 
RT for 4 days. Preserving a preloaded DMEK graft in tissue 
culture medium, however, leads to higher cell loss (approx-
imately 35%).6 7 This present study shows that prestripped, 
preloaded DMEK tissues shipped in organ culture medium 
plus dextran are comparative, and superior in some aspects, in 
suitability for transplant when compared with Optisol-stored 
grafts. The longer shelf-life and shipping temperature (RT) 
required for organ culture-stored grafts mean that this method 
may be more suitable for shipping to remote locations, 
expanding access to tissue worldwide.
Preloaded donor tissue will minimise surgical time and risks 
associated with preparation of DMEK, eliminating possible 
complications in the operating room. This will also reduce 
wastage of human corneal tissues, potentially providing a 
more standardised tissue. The prepared loading of the donor 
tissue into the single use delivery device can be advantageous. 
The increased costs related to precutting and preloading 
the tissue are balanced by the reduction in surgical time 
and instrumentation required to prepare the tissue. Regard-
less of the conditions and preparation or delivery methods, 
preloaded DMEK appears to be the future of lamellar surgery 
and may help less experienced surgeons to easily uptake this 
challenging surgery.
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